Nuzenio

Onclive Dr

Onclive Dr entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 24 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Timeline

Fri, 07 Aug 2026 20:36:49 GMTDr Thompson on 5-ARIs for Active Surveillance in Prostate Cancer - OncLive
Fri, 07 Aug 2026 20:20:25 GMTDr Akkus on the Second-Line Evidence Gap in Advanced HCC - OncLive
Fri, 07 Aug 2026 19:55:08 GMTDr Bazhenova on the Optimal Positioning of ADCs in Lung Cancer - OncLive
Fri, 07 Aug 2026 19:12:33 GMTDr Cohen on Future Research Avenues for Cevostamab in R/R Myeloma - OncLive
Fri, 07 Aug 2026 08:08:27 GMTDr Wong on the FDA Approval of Vusolimogene Oderparepvec-wtpg Plus Nivolumab in Melanoma - OncLive
Fri, 07 Aug 2026 03:24:28 GMTDr Brufsky on the FDA Approval of Gedatolisib Plus Fulvestrant ± Palbociclib in PIK3CA Wild-Type Breast Cancer - OncLive

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Onclive Dr.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.